G. Mato

A formulary for pediatric oncology in developing countries

R. Ribeiro, G. Masera, R. Barr, 2005, Pediatric blood & cancer.

Epidemiology of Biological-Exposure Incidents Among Spanish Healthcare Workers

J. Fereres, C. Fernández, V. Monge, 2001, Infection Control & Hospital Epidemiology.

Phase II window of idarubicin in children with extraocular retinoblastoma.

G. Chantada, S. Casak, A. Fandiño, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Activity of topotecan in retinoblastoma

G. Chantada, S. Casak, J. Manzitti, 2004, Ophthalmic Genetics.

Relationship between P-glycoprotein activity measured in peripheral blood mononuclear cells and indinavir bioavailability in healthy volunteers.

C. Höcht, F. Buontempo, M. Carballo, 2009, Journal of pharmaceutical sciences.

Therapeutic monitoring of pediatric renal transplant patients with conversion to generic cyclosporin

P. Schaiquevich, N. Riva, M. Monteverde, 2014, International Journal of Clinical Pharmacy.

Stability of melphalan solution for intravitreal injection for retinoblastoma.

P. Schaiquevich, E. Buitrago, E. Lagomarsino, 2014, JAMA ophthalmology.

[Pharmacovigilance of calcineurin inhibitor in peidatric kidney and liver transplantation].

P. Schaiquevich, N. Riva, O. Imventarza, 2013, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.